Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Peritoneal Neoplasms × Laparotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 Krukenberg Tumor 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Carboplatin 8 Paclitaxel 7 Hyperthermic Intraperitoneal Chemotherapy 7 Bevacizumab 4 liposomal doxorubicin 3 Gemcitabine 3 Oxaliplatin 2 Neoadjuvant Therapy 2 relacorilant 1 phenoxodiol 1 pembrolizumab 1 oregovomab 1 olaparib 1 nintedanib 1 lobaplatin 1 lanreotide 1 epothilone B 1 atezolizumab 1 Trabectedin 1 Topotecan 1 Therapeutics 1 Surgical Procedures, Operative 1 Saline Solution 1 Leucovorin 1 Letrozole 1 Laparotomy 1 Laparoscopy 1 LAIF 900 1 Hypericum extract LI 160 1 Glucose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01226394 2026-04-06

ProphyloCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡